Keystone Financial Group (Kentucky)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Keystone Financial Group (Kentucky)'s IBB Position: Q2 2026 in Review
Keystone Financial Group (Kentucky) reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q2 2026, selling an estimated $12.9K and leaving 2,282 shares worth $434K. The position accounts for 0.03% of the portfolio, ranked #354.
Keystone Financial Group (Kentucky) first reported a position in IBB in Q2 2019 and has held it in 19 quarters since. The position peaked at $450K in Q2 2020. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Keystone Financial Group (Kentucky) held 2,282 shares of iShares Biotechnology ETF worth $434K as of Q2 2026.
- Keystone Financial Group (Kentucky) sold 75 iShares Biotechnology ETF shares in Q2 2026, an estimated $12.9K.
- iShares Biotechnology ETF made up 0.03% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #354 holding.
- Keystone Financial Group (Kentucky) first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 19 quarters since.
- Keystone Financial Group (Kentucky)'s iShares Biotechnology ETF position peaked at $450K in Q2 2020.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.